Platform Processes Accelerating AAV Vector Production from Gene to Clinic Tom VanCott, Ph.D., Global Head of Product Development Tuesday, June 14 at 11:20am PT in the BioProcess International Theater |
|
|
| |
Current Realities of Make vs. Buy for Cell, Gene and Advanced Therapies Manufacturing Vic Vinci, Ph.D., Vice President of Product Development Wednesday, June 15 at 11:00am PT in Room 1B |
|
|
| |
Shortening Clinical Development Timelines Using Novel GPEx® Lightning Technology for Generating Stable, High Producing Cell Pools and Cell Lines Greg Bleck, Ph.D., Vice President of R&D Wednesday, June 15 at 11:20am PT in the BioProcess International Theater |
|
|
| |
Rapid Screening of Bioavailability Enhancing Technologies to Accelerate Time to Clinic Jesus Rosales Soto, Sr. Scientist for Oral Formulation Development Wednesday, June 15 at 1:05pm PT in the BioProcess International Theater |
|
|
| Meet Our Experts | | | Can’t Attend? Download This Executive Panel Discussion on the Post-COVID Supply Chain |
|
|
